On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayDec 13, 2017 9:31 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Subsidiary Spin Off

ChineseInvestors.com (OTCQB: CIIX) today announced plans to spin off its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., and its wholly-owned subsidiary, ChineseHempOil.com, Inc. in an effort to transition the subsidiary from a private startup to a successful public company. This change will allow the company to focus on its new Cryptocurrency Division and Core Financial Education Business. CIIX will be registered as a separate publically-traded company, and the Consumer Products Division (including its hemp oil assets and new wholesale alcohol division) will operate for both United States and China markets at the end of February 2018. The Company will pursue…

Continue Reading

WednesdayDec 13, 2017 9:13 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Executes LOI with SinglePoint, Inc. (SING)

Payment solutions company Global Payout (OTC: GOHE) this morning said that it has entered a Letter of Intent (“LOI”) with mobile technology provider SinglePoint (OTC: SING). Through this collaboration, Global Payout intends to build on its existing collection of financial technology solutions, including those used by its MoneyTrac Technology, Inc. (“MTRAC”) subsidiary. Additionally, the companies intend to examine potential technology optimization prospects that may be possible through the establishment of a joint venture. “SinglePoint’s knowledge and expertise in mobile payments and other mobile technology offerings is something we believe could be a significant addition to the financial payment platforms we…

Continue Reading

TuesdayDec 12, 2017 1:55 pm

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Directed by Executive Talent and Experience

Global Payout (OTC: GOHE) has distinguished itself as a premier global payment solutions provider lead by a seasoned executive team. An article discussing this reads: “Founder James Hancock, CEO and chairman of the board of Global Payout, has over thirty years’ experience in multiple executive capacities in financial services, investment banking, mergers and acquisitions, telecommunications and payment processing. Prior to founding Global Payout, Hancock, who holds a Juris Doctorate from the California School of Law, specialized in the financial services sector for 14 years and launched nearly 40 custom-designed prepaid debit card programs. Operating as a prepaid card services company,…

Continue Reading

TuesdayDec 12, 2017 1:55 pm

NetworkNewsBreaks — Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Plans to Ease Friction in Oil and Gas Industry with Supply Chain Platform

Oil and gas exploration company Petroteq Energy (TSX.V: PQE) (OTCQX: PQEFF) recently announced it will be developing a new blockchain platform in collaboration with First Bitcoin Capital Corp. (OTC: BITCF). The new supply chain management platform, named Petrobloq, is under development to be used in the global oil and gas industry. A recent article discussing the potential uses of blockchain reads: “The distributed ledger aspect of the technology means that new transactions and updates are circulated to all nodes on the network simultaneously. The information in the ledger, which is more like an accounting journal rather than a ledger, is…

Continue Reading

TuesdayDec 12, 2017 10:09 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Reports Key 2017 JV Achievements; Eyes Next Year’s Initiatives

SinglePoint (OTC: SING) today announced considerable growth in 2017 and success in key advances of its corporate mission with the launch of additional joint ventures and the closing of new deals within existing agreements. The company also provided a recap of 2017 achievements, as well as outlined key initiatives for 2018. Within the news release, SinglePoint president Wil Ralston stated, “Through strategic joint ventures and inside development of applications, we are pushing hard on providing a compliant solution to the cannabis industry. Our team and others have worked well in collaboration and believe we are not far away from an…

Continue Reading

TuesdayDec 12, 2017 9:55 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Completes Initial Audit Requirement to Up-List

PotNetwork Holding (OTC: POTN) today announced the successful completion of the first segment of its audit requirement for up-listing to the OTCQB, as well as long-term goal of achieving a NASDQ Capital Market listing. As part of the initial review, East West Accounting Services, LLC has satisfied compliance parameters and expects completion of the full audit by the second week of January 2018. Regarding successful completion of the initial phase, PotNetwork Holding CEO Rick Goulding stated in the news release, “We are very pleased that this segment of the process is completed.” To view the full press release, visit http://nnw.fm/WB4Hp…

Continue Reading

TuesdayDec 12, 2017 9:29 am

NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Inks LOI to Acquire Outstanding Shares of Harvest Medicine Inc.

Abcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning said that the company recently entered into a binding Letter of Intent (“LOI”) dated December 11, 2017 to acquire all outstanding securities of Canada’s fastest growing medical cannabis clinic, Harvest Medicine Inc. Per the terms of the agreement, Abcann will make a $1,500,000 cash payment and issue 1,056,338 common shares in the capital of ABcann valued at $1,500,000, based on a deemed price of $1.42 per share. Upon the closing of the transaction, Harvest Medicine founder and CEO, Shekhar Parmar, is anticipated to join ABcann’s executive team as Chief Strategy Officer and…

Continue Reading

MondayDec 11, 2017 2:45 pm

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Utilizes Proprietary Advanced Biosynthesis Process to Develop Cannabinoids-based Therapies

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) remains focused on discovering potential breakthrough cannabinoid-based therapies by utilizing its proprietary cannabinoid biosynthesis process and its bioinformatics drug and disease targeting tool. An article discussing this reads: “Other biopharmaceutical companies may produce cannabinoids in the laboratory using chemical synthesis, but there’s a litany of drug development efforts with synthetic molecules that have failed. The proprietary biosynthesis process used by InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) is unique. Producing cannabinoids that are identical to naturally occurring compounds is transformative for drug development. By using its proprietary process, InMed is able to manufacture exact…

Continue Reading

MondayDec 11, 2017 2:45 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Sets its Sights on Booming Global Cannabis Industry

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) patented delivery technology, DehydraTECH™ has positioned the company at the forefront of the thriving global cannabis industry. A recent article discussing this reads: “LXRP’s technology enables improved delivery of bioactive substances via oral ingestion that results in increased absorption without the need for unhealthy practices of inhalational dosing that result in damaging affects to the lungs. The technology also eliminates the need for co-administration with unhealthy sugars or sweeteners in delivery that are commonly used to mask the bitter tastes. With DehydraTECH™, bioactive substance delivery is improved by combining molecules with certain fatty acids…

Continue Reading

MondayDec 11, 2017 2:37 pm

NetworkNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Develops Cannabis-Based Therapeutics in Response to Opioid Epidemic

Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is using scientific research and development to stake out its spot in the medical marijuana industry. An article discussing this reads: “Veritas Pharma’s mission is to develop and commercialize the most effective cannabis strains, backed by clinical data. This innovative research and development path aims to solve the critical need for real science to support claims surrounding medical marijuana. The company’s approach, combined with its strategic alliances, will effectively address the medical community’s concerns over the complexities of cannabis potency, efficacy, quality and content in the…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217